![Amy Rabourn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Amy Rabourn
Treasurer at OCUPHIRE PHARMA, INC.
Net worth: 12 939 $ as of 30/05/2024
Amy Rabourn active positions
Companies | Position | Start | End |
---|---|---|---|
OCUPHIRE PHARMA, INC. | Treasurer | - | - |
Comptroller/Controller/Auditor | 10/11/2020 | - | |
Director of Finance/CFO | 30/11/2019 | 11/02/2024 |
Career history of Amy Rabourn
Former positions of Amy Rabourn
Companies | Position | Start | End |
---|---|---|---|
NEUROBO PHARMACEUTICALS, INC. | Director of Finance/CFO | 30/11/2014 | 30/11/2019 |
Training of Amy Rabourn
University of Michigan | Graduate Degree |
Statistics
International
United States | 4 |
Operational
Director of Finance/CFO | 2 |
Graduate Degree | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
OCUPHIRE PHARMA, INC. | Health Technology |
Private companies | 1 |
---|---|
Gemphire Therapeutics, Inc.
![]() Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI. | Health Technology |
- Stock Market
- Insiders
- Amy Rabourn
- Experience